Navigation Links
Antibodies from rabbits reduce risks associated with unrelated donor stem cell transplantation
Date:7/9/2012

Richmond, Va. (July 9, 2012) Researchers at Virginia Commonwealth University (VCU) Massey Cancer Center's Bone Marrow Transplant Program have demonstrated that the use of antibodies derived from rabbits can improve the survival and relapse outcomes of leukemia and myelodysplasia patients receiving a stem cell transplant from an unrelated donor.

Recently published in the journal Bone Marrow Transplantation, a study led by Amir Toor, M.D., hematologist-oncologist in the Bone Marrow Transplant Program and member of the Developmental Therapeutics program at VCU Massey Cancer Center, retrospectively compared the outcomes of 50 patients who received rabbit anti-thymocyte globulin (ATG) before receiving a transplant of stem cells from an unrelated donor to the outcomes of 48 patients who received a transplant of stem cells from a related donor. While unrelated stem cell transplants typically have poorer outcomes than related stem cell transplants, the results from this study showed similar outcomes for each group in terms of mortality, relapse and the development of graft-versus-host disease (GVHD), a common complication that can occur after a stem cell or bone marrow transplant in which the newly transplanted material attacks the transplant recipient's body.

"Unfortunately, we can't always find a related (genetically similar) donor for patients in need of stem cell transplantation," says Toor, who is also associate professor of internal medicine in the Department of Hematology, Oncology and Palliative Care at VCU School of Medicine. "Obtaining better outcomes with unrelated donor stem cell transplants could represent a significant advancement in extending the lives of more patients with blood cancers."

Unrelated donor stem cell transplants are generally considered a high-risk treatment due to historically higher rates of disease relapse and GVHD in comparison to stem cells transplanted from donors related to the patients. The results of the study indicat
'/>"/>

Contact: John Wallace
wallacej@vcu.edu
804-628-1550
Virginia Commonwealth University
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Antibodies from rabbits reduce risks associated with
2. Antibodies reverse type 1 diabetes in new immunotherapy study
3. HPV vaccine reduces infection, even in unvaccinated
4. Single embryo transfer reduces the risk of perinatal mortality in IVF
5. 5 or more cups of coffee a day reduce the chance of IVF success by around 50 percent
6. Higher levels of public reimbursement positively influence national birth rates and reduce unmet needs in subfertile populations
7. Nurse Alert Senior Medical Alert System Announces Solution for Seniors to Help Reduce Medical Costs
8. New technique could reduce number of animals needed to test chemical safety
9. Games improve employee health and well-being, may reduce health insurance premiums for employers
10. Progress in quest to reduce use of radiation in treatment of pediatric Hodgkin lymphoma
11. Study suggests touch therapy helps reduce pain, nausea in cancer patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... The American College of ... management and treatment of pulmonary arterial hypertension (PAH) ... in Adults: CHEST Guideline, in the journal CHEST. ... and provide the latest and most accurate treatment ... Association (PHA) – the country’s leading pulmonary ...
(Date:8/27/2014)... HealthDay Reporter WEDNESDAY, Aug. 27, 2014 (HealthDay ... alley will likely never want to return there, having associated ... neuroscientists working with mice say they,ve discovered the brain circuit ... emotions. And in rodent tests, they,ve manipulated brain cells to ... they made once-reluctant mice want to return to that dark ...
(Date:8/27/2014)... MI (PRWEB) August 27, 2014 Michigan Head ... help the children of a local elementary school by ensuring ... Siersma Elementary School has year-round attendance, and Michigan Head & ... to meet the new school year. , "There are a ... this is a great way to give back to our ...
(Date:8/27/2014)... The federal judge overseeing thousands of ... the deadline for plaintiffs to enroll in the U.S. ... by U.S. District Judge David Katz of the Northern ... DePuy ASR Settlement Program must do so by September ... Implant Products Liability Litigation – MDL 2197) , “Our ...
(Date:8/27/2014)... News) -- Pouring half a glass of wine at a time ... study. Researchers asked 74 college students and staff to pour ... had varying amounts of wine in them. The participants were told ... a "rule of thumb" about how much to pour -- such ... the top -- poured less wine than those without set guidelines. ...
Breaking Medicine News(10 mins):Health News:Pulmonary Hypertension Association Endorses CHEST Guidelines for Treatment of Pulmonary Arterial Hypertension in Adults 2Health News:Scientists 'Rewrite' Bad Memories in Mice 2Health News:Scientists 'Rewrite' Bad Memories in Mice 3Health News:Michigan Head & Neck Institute is Conducting Their 2nd Annual School Supplies Drive at Their Facility to Benefit Local Year-Round Elementary School Students 2Health News:DePuy ASR Settlement Enrollment Deadline Extended Until September 30, 2014, Bernstein Liebhard LLP Reports 2Health News:DePuy ASR Settlement Enrollment Deadline Extended Until September 30, 2014, Bernstein Liebhard LLP Reports 3Health News:'Half a Glass' Rule May Curb Overdrinking 2
... Center,s Average ER Wait TimePANAMA CITY, Fla., May 21 ... area to find out the average ER wait time at ... The hospital is posting its average ER wait times ... became the only hospital in our area to post our ...
... opened door to NUHW organizing effortOAKLAND, Calif., May 21 ... the recent decision by the California Public Employee Relations ... Medical Center (DMC) in San Pablo to continue. The ... violations of labor law by DMC management and organizers ...
... span in mice may hold hope for people, , , THURSDAY, ... discovered a way to boost chemotherapy and slightly extend the ... for more effective treatments in people. , There,s no guarantee ... it did, the researchers don,t expect that it would add ...
... and Financing Offerings Help Healthcare Providers to Accelerate ... May 21 Perot Systems Corporation (NYSE: ... today announced the availability of financing options to ... implementation of electronic health records which are being ...
... Committee, the region,s most prominent business organization, today applauded ... Board report in Atlanta, Georgia. Greater Baltimore Committee ... Board process has been of great value to the ... is appreciated by the business community. He is ...
... health and economic data like you,ve never seen it ... Hans Rosling will show how reproductive health ... will also illustrate how the convergence of conditions around ... "Western" and "developing" categories an outdated concept.On Tuesday, ...
Cached Medicine News:Health News:ER Wait Times at Your Fingertips 2Health News:Doctors Medical Center Election Tainted 2Health News:A New Way to Get Chemo to Pancreatic Tumors 2Health News:Perot Systems Announces Special Financing Options for Stimulus Plan Healthcare Technology Upgrades 2Health News:Perot Systems Announces Special Financing Options for Stimulus Plan Healthcare Technology Upgrades 3Health News:Gapminder's Hans Rosling Brings Poverty, Health Data to Life at Wilson Center 2
(Date:8/27/2014)... 2014 North American lighting leader OSRAM SYLVANIA ... for the new OSRAM ITOS ® PHASER ® ... for microscopy, endoscopy and surgical head lamps that delivers the ... and lamp life. "We,re honored to be recognized ... innovative new technologies of the past year," said Andreas ...
(Date:8/27/2014)... 27, 2014  Columbia Laboratories, Inc. (Nasdaq: ... pharmaceutical development, clinical trial manufacturing, and advanced analytical and ... it will participate at the upcoming Rodman & Renshaw ... held in New York . The ... September 9, 2014 at the New York Palace Hotel. ...
(Date:8/27/2014)... /CNW/ - Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: ... results for its third quarter of fiscal 2014: ... , Revenue of $1,291,378, a 13% decrease over the same ... the quarter of $240,156 compared to net income of $238,826 ... For the nine months ended June 30, 2014: ...
Breaking Medicine Technology:OSRAM ITOS PHASER 3000 Laser and LED Light Module Recognized With Prestigious R&D 100 Award 2OSRAM ITOS PHASER 3000 Laser and LED Light Module Recognized With Prestigious R&D 100 Award 3Covalon Announces Third Quarter Results 2Covalon Announces Third Quarter Results 3
... March 8, 2011 BioMarin Pharmaceutical Inc. (Nasdaq: ... of BioMarin, will present a company update at the Barclays ... at 4:15 p.m. ET.   Interested parties may ... the investor section of the BioMarin website, www.BMRN.com . ...
... (Nasdaq: VRML ) –Vermillion, a molecular ... data from its collaboration with Johns Hopkins University School ... specificity of CA125 for the identification of malignant ovarian ... Meeting on Women,s Cancer of the Society of Gynecologic ...
Cached Medicine Technology:BioMarin to Present at the Barclays Global Healthcare Conference 2Vermillion Announces Presentation of Positive Ovarian Biomarker Data for Next Generation Test 2Vermillion Announces Presentation of Positive Ovarian Biomarker Data for Next Generation Test 3
Modified Freer periosteal elevator, #163, slight curve, 21 cm....
Williger periosteal elevator, 6 1/4", sharp, 5 mm wide....
Alley periosteal elevator, extra long, 21 cm, 8-1/4"....
Periosteal elevator #9H, 17.5 cm, 7"....
Medicine Products: